 4. Patient has evidence of significant cardiovascular disease, including myocardial infarction, unstable angina, coronary bypass surgery, percutaneous transluminal coronary angioplasty PTCA, congestive heart failure New York Heart Association Class III-IV, stroke, or severe ischemic disease within 3 months before screening. 